Because eNOS is upregulated by VEGF, inhibition of VEGF by neutralizing antibodies or a VEGFR blocker leads to a decrease in nitric oxide production in endothelial cells that may account for the development of hypertension [23]. The gene discussed is VEGFA; the disease is Hypertension.